Publications

Selected key publications:

1.     Kurtz DM, Soo J, Co Ting Keh, L, Alig, S, Chabon JJ, Sworder BJ, Schultz A, Jin MC, Scherer F, Garofalo A, Macaulay CW, Hamilton EG, Chen B, Olsen M, Schroers-Martin, JG, Craig AFM, Moding E, Esfahani MS, Liu CL, Dührsen U, Hüttman A, Casasnovas RO, Westin JR, Roschewski M, Wilson WH, Gaidano G, Rossi D, Diehn M, Alizadeh AA. Phased variant enrichment for enhanced disease detection from cell-free DNA. Nature Biotechnology. 2021 Jul 22. (Online ahead of print). PubMed PMID: 34294911.

2.     Alig S*, Macaulay CW*, Kurtz DM*, Dührsen U, Hüttman A, Schmitz C, Jin MC, Sworder BJ, Garofalo A, Esfahani MS, Nabet BY, Soo J, Scherer F, Craig AFM, Casasnovas RO, Westin JR, Gaidano G, Rossi D, Roschewski M, Wilson WH, Meignan M, Diehn M, Alizadeh AA. Short diagnosis-to-treatment interval is associated with higher circulating tumor DNA levels in diffuse large B-cell lymphoma. Journal of Clinical Oncology. 2021; 39(23):2605-2616. PubMed PMID: 33909455.

3.     Cirillo M, Craig AFM, Borchmann S, Kurtz DM. Liquid biopsy in lymphoma: Molecular methods and clinical applications. Cancer Treat Reviews. 2020; 91:102106.

4.     Chabon JJ*, Hamilton EG*, Kurtz DM*, Esfahani MS*, Moding EJ, Stehr H, Schroers-Martin J, Nabet BY, Chen B, Chaudhuri AA, Liu CL, Hui AB, Jin MC, Azad TD, Almanza D, Jeon YJ, Nesselbush MC, Keh LCT, Bonilla RF, Yoo CH, Ko RB, Chen EL, Merriott DJ, Massion PP, Mansfield AS, Jen J, Ren HZ, Lin SH, Costantino CL, Burr R, Tibshirani R, Gambhir SS, Berry GJ, Jensen KC, West RB, Neal JW, Wakelee HA, Loo BW, Kunder CA, Leung AN, Liu NS, Merry MF, Shrager JB, Nair VS, Haber DA, Sequist LV, Alizadeh AA, Diehn M. Integrating genomic features for noninvasive early lung cancer detection. Nature. 2020; 580(7802):245-251.

5.     Kurtz DM. Prognostication with circulating tumor DNA: is it ready for prime time? Hematology, ASH Education Program. 2019; 2019(1):47-52.

6.     Kurtz DM*, Esfahani MS*, Scherer F*, Soo J, Jin MC, Liu CL, Newman AM, Dührsen U, Hüttman A, Casasnovas RO, Westin JR, Ritgen M, Böttcher S, Langerak AW, Roschewski M, Wilson WH, Gaidano G, Rossi D, Bahlo J, Hallek M, Tibshirani R, Diehn M, Alizadeh AA. Dynamic risk profiling using serial tumor biomarkers for personalized outcome prediction. Cell. 2019; 178(3):669-713.

7.     Kurtz DM*, Scherer F*, Jin MC, Soo J, Craig AFM, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust MS, Advani RH, Levy R, Newman AM, Dührsen U, Hüttman A, Meignan M, Casasnovas RO, Westin JR, Roschewski M, Wilson WH, Gaidano G, Rossi D, Diehn M, Alizadeh AA. Circulating tumor DNA measurements as early outcome predictors in diffuse large B-cell lymphoma. Journal of Clinical Oncology. 2018; 36(28):2845-2853.

8.     Scherer F*, Kurtz DM*, Newman AM*, Stehr H, Craig AFM, Esfahani MS, Lovejoy AF, Chabon JJ, Klass DM, Liu CL, Zhou L, Glover C, Visser BV, Poultsides GA, Advani RH, Maeda LS, Gupta NK, Levy R, Ohgami RS, Kunder CA, Diehn M, Alizadeh AA. Distinct biological subtypes and patterns of genome evolution in lymphoma patients revealed by circulating tumor DNA. Science Translational Medicine. 2016; 8(365):364ra155.

9.     Kurtz DM*, Green MR*, Bratman SV, Scherer F, Liu CL, Kunder CA, Takahashi K, Glover C, Keane C, Kihira S, Visser B, Callahan J, Kong KA, Faham M, Corbelli KS, Miklos D, Advani RH, Levy R, Hicks RJ, Hertzberg M, Ohgami RS, Gandhi MK, Diehn M, Alizadeh AA.  Non-invasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.  Blood. 2015; 125(24):3679-87.

Click here for a full list of Prof. Kurtz's publications.